Asep Medical Holdings Inc
SEPSF · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 1.1% | 0% | 250% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 54.9% | 46.8% | -342.3% | -259.1% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -851.5% | -1,361.7% | -818.5% | -9,341.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -980.4% | -1,516.8% | -1,029.9% | -9,543.8% |
| EPS Diluted | -0.01 | -0.015 | -0.01 | -0.027 |
| % Growth | 34.7% | -44.1% | 62.5% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |